Hypertension in rheumatoid arthritis
Panoulas, Vasileios F. Metsios, Giorgos S. Pace, A.V. John, H. Treharne, G.J. Banks, M.J. Kitas, George D.
Panoulas, Vasileios F.
Metsios, Giorgos S.
Pace, A.V.
John, H.
Treharne, G.J.
Banks, M.J.
Kitas, George D.
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2008
Submitted date
Alternative
Abstract
RA associates with an increased burden of cardiovascular disease, which is at least partially attributed to classical risk factors such as hypertension (HT) and dyslipidaemia. HT is highly prevalent, and seems to be under-diagnosed and under-treated among patients with RA. In this review, we discuss the mechanisms that may lead to increased blood pressure in such patients, paying particular attention to commonly used drugs for the treatment of RA. We also suggest screening strategies and management algorithms for HT, specific to the RA population, although it is clear that these need to be formally assessed in prospective randomized controlled trials designed specifically for the purpose, which, unfortunately, are currently lacking.
Citation
Rheumatology, 47(9): 1286-1298
Publisher
Journal
Research Unit
PubMed ID
18467370
PubMed Central ID
Embedded videos
Type
Journal article
Language
en
Description
Series/Report no.
ISSN
1462-0332